Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Feb 28;72(4):611–621. doi: 10.1093/cid/ciaa061

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Published by Oxford University Press for the Infectious Diseases Society of America 2020.

This work is written by (a) US Government employee(s) and is in the public domain in the US.

PMC Copyright notice

Figure 1. — Encounter flowsheet. ^aList of select antibiotics in which ceftazidime-avibactam was prescribed: amikacin, aztreonam, ceftazidime, chloramphenicol, colistin, imipenem/cilastatin, minocycline, ampicillin/sulbactam, ticarcillin/clavulanate/tobramycin, ertapenem, tigecycline, fosfomycin, doripenem, ceftazidime-avibactam, ceftolozane-tazobactam, piperacillin-tazobactam, ciprofloxacin, cefepime, meropenem, levofloxacin, gentamicin. ^bPatients non–mutually exclusive as encounters who received concomitant ceftazidime-avibactam and colistin are not removed and they may have multiple encounters across different therapy categories and multiple encounters within a therapy category. Abbreviation: q, quarter.